Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091483385> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W3091483385 endingPage "100" @default.
- W3091483385 startingPage "89" @default.
- W3091483385 abstract "Background: Invasive aspergillosis (IA) is associated with high morbidity and mortality, particularly among immunocompromised patients, such as lung transplant recipients. Voriconazole, the first-line therapy for IA, shows a non-linear pharmacokinetic profile and has a narrow therapeutic range. Careful and appropriate administration is necessary, primarily because it is used for critically ill patients; however, the clinical usefulness of therapeutic drug monitoring (TDM) has not been sufficiently verified. Therefore, in this study, we validated the safety and efficacy of voriconazole TDM in lung transplant recipients receiving only voriconazole for IA treatment. Methods: The electronic medical records of lung transplant recipients (≥19 years of age) administered only voriconazole for > 7 days for treatment of IA from June 1, 2013 to May 31, 2018 were analyzed retrospectively. Results: Among the 54 patients, 27 each were allocated to TDM and non-TDM groups, respectively. There were no significant differences in patient characteristics between the two groups except for ICU-hospitalization status. Of the TDM group patients, 81.5% needed adjustment of voriconazole dosage because the levels were out of target range. Comparison of two groups showed that treatment response was higher throughout treatment and switching rates of second-line agents were significantly lower in the TDM group, but it was insufficient to confirm safety improvements through voriconazole TDM. Conclusions: Considering that the treatment response tended to be higher and the rates of switching to second-line antifungal agents were lower in the TDM group, voriconazole TDM may increase the therapeutic effect on IA in lung transplant patients." @default.
- W3091483385 created "2020-10-08" @default.
- W3091483385 creator A5000788471 @default.
- W3091483385 creator A5001481344 @default.
- W3091483385 creator A5056047256 @default.
- W3091483385 creator A5066450023 @default.
- W3091483385 creator A5070820013 @default.
- W3091483385 creator A5085313476 @default.
- W3091483385 date "2019-06-01" @default.
- W3091483385 modified "2023-09-22" @default.
- W3091483385 title "침습성 아스페르길루스증의 치료 목적으로 voriconazole을 단독으로 투여받는 폐이식 환자에서 voriconazole 약물혈중농도 모니터링의 유효성 검증" @default.
- W3091483385 hasPublicationYear "2019" @default.
- W3091483385 type Work @default.
- W3091483385 sameAs 3091483385 @default.
- W3091483385 citedByCount "0" @default.
- W3091483385 crossrefType "journal-article" @default.
- W3091483385 hasAuthorship W3091483385A5000788471 @default.
- W3091483385 hasAuthorship W3091483385A5001481344 @default.
- W3091483385 hasAuthorship W3091483385A5056047256 @default.
- W3091483385 hasAuthorship W3091483385A5066450023 @default.
- W3091483385 hasAuthorship W3091483385A5070820013 @default.
- W3091483385 hasAuthorship W3091483385A5085313476 @default.
- W3091483385 hasConcept C112705442 @default.
- W3091483385 hasConcept C126322002 @default.
- W3091483385 hasConcept C141071460 @default.
- W3091483385 hasConcept C16005928 @default.
- W3091483385 hasConcept C177713679 @default.
- W3091483385 hasConcept C203014093 @default.
- W3091483385 hasConcept C2776391196 @default.
- W3091483385 hasConcept C2777714996 @default.
- W3091483385 hasConcept C2779548794 @default.
- W3091483385 hasConcept C2780272996 @default.
- W3091483385 hasConcept C2780690907 @default.
- W3091483385 hasConcept C2781448352 @default.
- W3091483385 hasConcept C71924100 @default.
- W3091483385 hasConceptScore W3091483385C112705442 @default.
- W3091483385 hasConceptScore W3091483385C126322002 @default.
- W3091483385 hasConceptScore W3091483385C141071460 @default.
- W3091483385 hasConceptScore W3091483385C16005928 @default.
- W3091483385 hasConceptScore W3091483385C177713679 @default.
- W3091483385 hasConceptScore W3091483385C203014093 @default.
- W3091483385 hasConceptScore W3091483385C2776391196 @default.
- W3091483385 hasConceptScore W3091483385C2777714996 @default.
- W3091483385 hasConceptScore W3091483385C2779548794 @default.
- W3091483385 hasConceptScore W3091483385C2780272996 @default.
- W3091483385 hasConceptScore W3091483385C2780690907 @default.
- W3091483385 hasConceptScore W3091483385C2781448352 @default.
- W3091483385 hasConceptScore W3091483385C71924100 @default.
- W3091483385 hasIssue "2" @default.
- W3091483385 hasLocation W30914833851 @default.
- W3091483385 hasOpenAccess W3091483385 @default.
- W3091483385 hasPrimaryLocation W30914833851 @default.
- W3091483385 hasVolume "29" @default.
- W3091483385 isParatext "false" @default.
- W3091483385 isRetracted "false" @default.
- W3091483385 magId "3091483385" @default.
- W3091483385 workType "article" @default.